Catalyst Funds Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-900
Closed -$52.1K 1311
2024
Q3
$52.1K Buy
900
+500
+125% +$24.6K 0.01% 777
2024
Q2
$16.2K Buy
+400
New +$15.9K ﹤0.01% 753

Other funds holding ASTH

Catalyst Funds Management's ASTH Position: Q4 2024 in Review

Catalyst Funds Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 900 shares — an estimated $52.1K sold.

Catalyst Funds Management first reported a position in ASTH in Q2 2024 and held it in 2 quarters. The position peaked at $52.1K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Catalyst Funds Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 900 Astrana Health shares in Q4 2024, an estimated $52.1K.
  • Catalyst Funds Management first reported a position in Astrana Health in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Astrana Health position peaked at $52.1K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.